Why the study?
Breast cancer and cardiovascular disease share common risk factors, and several metastatic breast cancer therapies cause cardiac effects, highlighting the need to prevent, identify, and manage cardiovascular events.
Integrating routine cardiac monitoring into the care of patients with metastatic breast cancer is essential to mitigate the cardiovascular risks associated with both the disease and its treatments.
No takes yet. Share an insight, caveat, or question.
Highlights need for cardiac monitoring in metastatic breast cancer; leaves open optimal protocols pending prospective trials.
Curigliano et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: